Progression-free survival and overall survival in phase III trials of molecular-targeted agents in advanced non-small-cell lung cancer-Reference-Cited by-同舟云学术

Progression-free survival and overall survival in phase III trials of molecular-targeted agents in advanced non-small-cell lung cancer

Published:2013-01 Issue:1 Volume:79 Page:20-26
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Hotta Katsuyuki,Suzuki Etsuji,Di Maio Massimo,Chiodini Paolo,Fujiwara Yoshiro,Takigawa Nagio,Ichihara Eiki,Reck Martin,Manegold Christian,Pilz Lothar,Hisamoto-Sato Akiko,Tabata Masahiro,Tanimoto Mitsune,Shepherd Frances A.,Kiura Katsuyuki

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference36 articles.

1. Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomized clinical trials;Non-Small Cell Lung Cancer Collaborative Group;BMJ,1995

2. Meta-analysis of randomized clinical trials comparing cisplatin to carboplatin in patients with advanced non-small-cell lung cancer;Hotta;J Clin Oncol,2004

3. Long-standing debate on cisplatin- versus carboplatin-based chemotherapy in the treatment of advanced non-small-cell lung cancer;Hotta;J Thorac Oncol,2007

4. Recent improvement in the survival of patients with advanced non-small-cell lung cancer enrolled in phase III trials of first-line systemic chemotherapy;Hotta;Cancer,2007

5. Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer;Scagliotti;J Clin Oncol,2008

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-World Pattern of Treatment and Clinical Outcomes of EGFR-Mutant Non-Small Cell Lung Cancer in a Single Academic Centre in Quebec;Current Oncology;2021-12-07

2. Surrogate Endpoints in Oncology: Overview of Systematic Reviews and Their Use for Health Decision Making in Mexico;Value in Health Regional Issues;2021-12

3. Comparison of afatinib and osimertinib effect on overall survival in first-line drug treatment of EGFR-positive metastatic non-small cell lung cancer: network meta-analysis;Journal of Modern Oncology;2021-11-19

4. Impact of Advantage in Tumor Response on the Correlation Between Progression-Free Survival and Overall Survival: Meta-Analysis of Clinical Trials in Patients with Advanced Non-Small Cell Lung Cancer;Pharmaceutical Medicine;2021-01-23

5. Trends in Phase II Trials for Cancer Therapies;Cancers;2021-01-07